Tw. Fossum et al., Complications common to ventricular assist device support are rare with 90days of DeBakey VAD (R) support in calves, ASAIO J, 47(3), 2001, pp. 288-292
The DeBakey VAD (R) is a miniaturized, electromagnetically driven axial flo
w pump intended for long-term ventricular assist. Safety and performance da
ta from six calves implanted with the complete DeBakey VAD (R) system are r
eported elsewhere; here we describe complications and necropsy findings for
these same six animals, all of which survived 90 days. The study was condu
cted according to a uniform protocol, which included anticoagulation and an
tibiotic prophylaxis. Clinical complications tracked included bleeding, car
diovascular abnormalities (e.g., arrhythmias, tachycardia unrelated to pain
, bradycardia), hemolysis, hepatic dysfunction, renal dysfunction, thromboe
mbolism (neurologic or peripheral), or infection. Each adverse event was re
trospectively categorized with regard to severity (mild, moderate, severe)
and relationship to device. Clinical findings were confirmed by necropsy. T
here was no evidence of systemic infection, thromboembolism, hemolysis, or
renal or hepatic dysfunction in these six animals during the study period.
A single adverse event was noted in each of two of the calves. Both events
were considered mild according to the predefined criteria. Bleeding related
to the surgical implantation procedure and requiring reoperation occurred
in one animal. The other animal had evidence of a superficial infection at
the exit site of the cables on the left lateral thoracic wall; the infectio
n did not extend into the thoracic cavity. Chronic, healed small renal infa
rct scars were present in several animals. Mild valvular endocardiosis was
observed in two calves and mild fibroelastosis was present in the endocardi
um at the site of the inflow cannula in three calves; however, these lesion
s were not considered clinically significant No other gross or histologic a
bnormalities were noted at necropsy. In conclusion, calves implanted with t
he complete DeBakey VAD (R) for 90 days demonstrated few complications and
had no significant necropsy findings. Complications common to ventricular a
ssist device (VAD) support (i.e., hemolysis, infection, bleeding, thromboem
bolism) were rare during long-term support (90 days) with the DeBakey VAD.